Key takeaway
Across 13 randomised trials, combined diet and physical activity interventions in type 2 diabetes changed HbA1c by -0.53% overall (95% CI -0.74 to -0.32, P < 0.00001) and body weight by -3.73 kg (95% CI -6.09 to -1.37 kg, P = 0.002) versus controls. The HbA1c benefit was clinically significant at three and six months but not at 12 and 24 months.
Study design
Evidence review
Reading basis
Published abstract
Reading focus
Design & applicability
The research question
Changing diet and activity is central to treating type 2 diabetes, yet changing behaviour is hard. The authors set out to identify which behaviour change techniques (BCTs) and intervention features are linked to changes in HbA1c and body weight.
Who and how
Systematic review and meta-analysis of randomised controlled trials published between 1975 and 2015 that focused exclusively on both diet and physical activity in type 2 diabetes. Thirteen trials were found. The authors coded the BCTs, intervention features and methodological rigour of each intervention, then meta-analysed changes in HbA1c and body weight and examined them in relation to BCT use.
What it found
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1HbA1c changed more in intervention than control groups at 3, 6, 12 and 24 months, by -1.11% (12 mmol/mol), -0.67% (7 mmol/mol), -0.28% (3 mmol/mol) and -0.26% (2 mmol/mol), with an overall change of -0.53% (6 mmol/mol; 95% CI -0.74 to -0.32, P < 0.00001).
- 2Body weight changed by -2.7 kg, -3.64 kg, -3.77 kg and -3.18 kg at 3, 6, 12 and 24 months, with an overall change of -3.73 kg (95% CI -6.09 to -1.37 kg, P = 0.002).
- 3Four of 46 BCTs were associated with more than 0.3% HbA1c reduction: instruction on how to perform a behaviour, behavioural practice or rehearsal, demonstration of the behaviour, and action planning.
- 4Features linked to larger HbA1c reductions included supervised physical activity, group sessions, contact with an exercise physiologist (alone or with a dietitian), baseline HbA1c above 8%, and interventions of greater frequency and intensity.
Limits & uncertainty
- 1Only 13 trials were included, so each BCT or feature comparison rests on a small number of studies.
- 2The BCT and feature analyses link techniques to outcomes across trials, so they are associations and not proof that a given technique caused the benefit.
- 3The abstract does not report heterogeneity between trials or their risk of bias.
- 4HbA1c improvements shrank over time (from -1.11% at 3 months to -0.26% at 24 months). This reading is based on the abstract only.
What to take from it
Structured programs that combine diet and activity can lower HbA1c and weight for people with type 2 diabetes, especially in the first six months, and the most useful ingredients were hands-on: teaching, demonstrating, practising and planning. Keeping the benefit going seems harder. Any change to diabetes care should be agreed with your clinician.
Reading your own data
HbA1c is a lab test, but CGM time-in-range, fasting glucose, weight trends, step counts and workout logs can show whether your routine is holding up over months. Compare like with like (same scale, same time of day, same device), and expect early gains to ease, so plan for what keeps you going after the first six months.
How to read this evidence
Check which designs were included, how searches and bias assessment were conducted, and the last search date. Publication date alone does not make the underlying evidence current.
Authors’ structured abstract English
The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.
Background
Changing diet and physical activity behaviour is one of the cornerstones of type 2 diabetes treatment, but changing behaviour is challenging. The objective of this study was to identify behaviour change techniques (BCTs) and intervention features of dietary and physical activity interventions for patients with type 2 diabetes that are associated with changes in HbA_(1c) and body weight.
Methods
We performed a systematic review of papers published between 1975-2015 describing randomised controlled trials (RCTs) that focused exclusively on both diet and physical activity. The constituent BCTs, intervention features and methodological rigour of these interventions were evaluated. Changes in HbA_(1c) and body weight were meta-analysed and examined in relation to use of BCTs.
Results
Thirteen RCTs were identified. Meta-analyses revealed reductions in HbA_(1c) at 3, 6, 12 and 24 months of -1.11 % (12 mmol/mol), -0.67 % (7 mmol/mol), -0.28 % (3 mmol/mol) and -0.26 % (2 mmol/mol) with an overall reduction of -0.53 % (6 mmol/mol [95 % CI -0.74 to -0.32, P < 0.00001]) in intervention groups compared to control groups. Meta-analyses also showed a reduction in body weight of -2.7 kg, -3.64 kg, -3.77 kg and -3.18 kg at 3, 6, 12 and 24 months, overall reduction was -3.73 kg (95 % CI -6.09 to -1.37 kg, P = 0.002). Four of 46 BCTs identified were associated with >0.3 % reduction in HbA_(1c): 'instruction on how to perform a behaviour', 'behavioural practice/rehearsal', 'demonstration of the behaviour' and 'action planning', as were intervention features 'supervised physical activity', 'group sessions', 'contact with an exercise physiologist', 'contact with an exercise physiologist and a dietitian', 'baseline HbA_(1c) >8 %' and interventions of greater frequency and intensity.
Conclusions
Diet and physical activity interventions achieved clinically significant reductions in HbA_(1c) at three and six months, but not at 12 and 24 months. Specific BCTs and intervention features identified may inform more effective structured lifestyle intervention treatment strategies for type 2 diabetes.
Sources & attribution
Behaviour change techniques targeting both diet and physical activity in type 2 diabetes: A systematic review and meta-analysis.
Cradock KA, ÓLaighin G, Finucane FM, Gainforth HL, Quinlan LR, Ginis KA.
The international journal of behavioral nutrition and physical activity · 2017-02-08
DOI: 10.1186/s12966-016-0436-0 ↗PubMed · 28178985 ↗Europe PMC · Recorded licence: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
MoveVitals editorial interpretation · educational content · no individual clinical review recorded
Sources checked 2026-11-01
Practical guides
Read in context
7,000 steps a day linked to lower risk of death, heart disease and dementia than 2,000
Compared with 2000 steps a day, 7000 steps was associated with a hazard ratio of 0.53 (95% CI 0.46 to 0.60) for all-cause mortality across 14 studies, 0.75 (0.67 to 0.85) for cardiovascular disease and 0.62 (0.53 to 0.73) for dementia; cancer incidence was not significantly different (0.94, 0.87 to 1.01). Several outcomes rest on only two to four studies, and the certainty of evidence ranged from moderate to very low.
The Lancet Public Health
Brief bursts of vigorous effort in daily life linked to lower mortality in non-exercisers
Among 25,241 UK Biobank adults who reported no leisure-time exercise, a median of 3 vigorous bouts of 1 or 2 minutes a day, picked up by a wrist accelerometer, was associated with a 38% to 40% lower risk of all-cause and cancer death and a 48% to 49% lower risk of cardiovascular death than no such bouts, over an average of 6.9 years and 852 deaths. This is an observational study using one week of wrist data and an algorithm to define vigorous effort, so it cannot show that adding such bursts causes the lower risk.
Nature Medicine
Steps and mortality: gains flatten near 6,000–8,000 (age 60+) and 8,000–10,000 (under 60)
Pooling 15 cohorts (47,471 adults, 3,013 deaths, median follow-up 7.1 years), the second, third and fourth quartiles of daily steps (medians 5,801, 7,842 and 10,901) had hazard ratios for death of 0.60, 0.55 and 0.47 against the lowest quartile (median 3,553). The curve flattened at about 6,000 to 8,000 steps a day for adults aged 60 and over and 8,000 to 10,000 for younger adults. The data are observational, from a single week of step counting, mostly with waist-worn research devices.
The Lancet Public Health
Accelerometers on 36,383 adults: any activity, even light, linked to lower mortality
In eight pooled cohorts (36,383 adults, mean age 62.6 years, 2,149 deaths over a median 5.8 years), the most active quarter by accelerometer-measured total activity had a mortality hazard ratio of 0.27 (95% CI 0.23 to 0.32) against the least active, and the most sedentary quarter had 2.63 (1.94 to 3.56). Light activity alone showed the same pattern, with 0.38 (0.28 to 0.51) in the top quarter. These are observational associations in adults aged 40 and over from the US and western Europe, so illness-driven inactivity and confounding cannot be excluded.
BMJ

